Status:
COMPLETED
Non-invasive Secondary Respiratory Support in Late Preterm and Term Infants
Lead Sponsor:
Alexandria University
Conditions:
Neonates
Respiratory Distress
Eligibility:
All Genders
1-14 years
Phase:
NA
Brief Summary
The aim of the present work is to compare between various modes of non-invasive respiratory support (including NCPAP, NIPPV, and NHFOV) as secondary respiratory support modes in late preterm and term ...
Eligibility Criteria
Inclusion
- The gestational age (GA) is between 34 and 41 weeks.
- Extubation from invasive mechanical ventilation initiated due to RD, irrespective to the cause of RD.
- Respiratory distress is assessed based on clinical manifestations (tachypnea, nasal flaring, intercostal retractions, diminished air entry, and or grunting)
Exclusion
- Major congenital anomalies.
- Major cardiac diseases.
- Presence of cardiovascular instability (sepsis, severe dehydration, severe anemia).
- Neurologically insulted neonates who are unable to take adequate spontaneous breathing.
Key Trial Info
Start Date :
July 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT07000071
Start Date
July 1 2021
End Date
January 30 2022
Last Update
May 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marwa Mohamed Farag
Alexandria, Egypt, 0325